Quarter Period Statement Of Income

ONO PHARMACEUTICAL CO., LTD. - Filing #7602299

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Quarter period statement of income
Statement of income
Net sales
357,023,000,000 JPY
305,183,000,000 JPY
Cost of sales
87,630,000,000 JPY
78,774,000,000 JPY
Gross profit (loss)
269,393,000,000 JPY
226,409,000,000 JPY
Selling, general and administrative expenses
149,494,000,000 JPY
141,481,000,000 JPY
Selling, general and administrative expenses
Salaries
12,741,000,000 JPY
12,412,000,000 JPY
Depreciation
680,000,000 JPY
591,000,000 JPY
Operating profit (loss)
119,899,000,000 JPY
84,929,000,000 JPY
Non-operating income
Interest income
27,000,000 JPY
27,000,000 JPY
Dividend income
2,315,000,000 JPY
2,401,000,000 JPY
Non-operating income
3,318,000,000 JPY
4,191,000,000 JPY
Non-operating expenses
Interest expenses
36,000,000 JPY
38,000,000 JPY
Non-operating expenses
2,160,000,000 JPY
2,342,000,000 JPY
Ordinary profit (loss)
121,057,000,000 JPY
86,778,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
501,000,000 JPY
Extraordinary income
14,526,000,000 JPY
14,400,000,000 JPY
Extraordinary losses
Extraordinary losses
11,166,000,000 JPY
JPY
Profit (loss) before income taxes
124,417,000,000 JPY
101,178,000,000 JPY
Income taxes - current
13,069,000,000 JPY
31,267,000,000 JPY
Income taxes - deferred
16,754,000,000 JPY
-7,016,000,000 JPY
Income taxes
29,823,000,000 JPY
24,251,000,000 JPY
Profit (loss)
94,594,000,000 JPY
94,594,000,000 JPY
94,594,000,000 JPY
94,594,000,000 JPY
76,927,000,000 JPY
76,927,000,000 JPY
76,927,000,000 JPY
76,927,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.